Manchikanti L, Benyamin RM, Swicegood JR, et al. Assessment of practice patterns of perioperative management of antiplatelet and anticoagulant therapy in interventional pain management. Pain Physician. 2012;15:E955–68.
Manchikanti L, Abdi S, Atluri S, et al. An update of comprehensive evidence-based guidelines for interventional techniques of chronic spinal pain: part II: guidance and recommendations. Pain Physician. 2013;16:S49–S283.
World Health Organization. Cardiovascular disease (CVDs) fact sheet. 2012. www.who.int/mediacentre/factsheets/fs317/en/index.html
Schiller JS, Lucas JW, Ward BW, et al. Summary health statistics for U.S. adults: National Health Interview Survey, 2010. Vital Health Stat. 2012;252:1–207.
Institute of Medicine (IOM). Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: The National Academies Press; 2011.
Freburger JK, Holmes GM, Agans RP, et al. The rising prevalence of chronic low back pain. Arch Intern Med. 2009;169:251–8.
Hoy DG, Bain C, Williams G, et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012;64:2028–37.
Hoy DG, Protani M, De R, et al. The epidemiology of neck pain. Best Pract Res Clin Rheumatol. 2010;24:783–92.
Martin BI, Turner JA, Mirza SK, et al. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006. Spine (Phila Pa 1976). 2009;34:2077–84.
Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012;13:715–24.
Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006;27:2667–74.
Price MJ, Berger PB, Teirstein PS, et al; GRAVITAS Investigators. Standard- vs high dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA. 2011;305:1097–105.
Ho PM, Peterson ED, Wang L, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA. 2008;299:532–9. Erratum in: JAMA 2008; 299:2390
Johnson SG, Rogers K, Delate T, et al. Outcomes associated with combined antiplatelet and anticoagulant therapy. Chest. 2008;133:948–54.
Marso SP, Amin AP, House JA, et al; National Cardiovascular Data Registry. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA. 2010;303:2156–64.
Chan AT, Giovannucci EL, Meyerhardt JA, et al. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA. 2005;294:914–23.
Berger JS, Krantz MJ, Kittelson JM, et al. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA. 2009;301:1909–19.
Howard-Alpe GM, de Bono J, Hudsmith L, et al. Coronary artery stents and non-cardiac surgery. Br J Anaesth. 2007;98:560–74.
Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297:159–68.
Ogawa H, Nakayama M, Morimoto T, et al; Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) Trial Investigators. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA. 2008;300:2134–41. Erratum in: JAMA 2009;301:1882.
Paikin JS, Wright DS, Eikelboom JW. Effectiveness and safety of combined antiplatelet and anticoagulant therapy: a critical review of the evidence from randomized controlled trials. Blood Rev. 2011;25:123–9.
Sprigg N, Gray LJ, England T, et al. A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility. PLoS One. 2008;3:e2852.
Walker CW, Dawley CA, Fletcher SF. Aspirin combined with clopidogrel (Plavix) decreases cardiovascular events in patients with acute coronary syndrome. Am Fam Physician. 2007;76:1643–5.
Manchikanti L, Malla Y, Wargo BW, et al. A prospective evaluation of bleeding risk of interventional techniques in chronic pain. Pain Physician. 2011;14:317–29.
Manchikanti L, Falco FJE, Benyamin RM, et al. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy. Pain Physician. 2013;16:SE261–318.
Horlocker TT, Wedel DJ, Schroeder DR, et al. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg. 1995;80:303–9.
Horlocker TT, Wedel DJ, Offord KP. Does preoperative antiplatelet therapy increase the risk of hemorrhagic complications associated with regional anesthesia? Anesth Analg. 1990;70:631-634.
Horlocker TT, Wedel DJ, Rowlingson JC, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition). Reg Anesth Pain Med. 2010;35:64–101.
Raj PP, Shah RV, Kaye AD, et al. Bleeding risk in interventional pain practice: assessment, management, and review of the literature. Pain Physician. 2004;7:3–51.
Ahmed SU, Tonidandel W, Trella J, et al. Peri-procedural protocols for interventional pain management techniques: a survey of US pain centers. Pain Physician. 2005;8:181–5.
Gogarten W, Van Aken H, Buttner J, et al. Neuraxial blockade and thromboembolism prophylaxis/antithrombotic therapy: revised recommendations of the German Society of Anaesthesiology and Intensive Care. Anaesthesiol Intensivmed. 2003;44:218–30.
Bugada D, Massimo A, Nicola Z, et al. Regional anesthesia and anticoagulant drugs: a survey of current Italian practice. Eur J Pain Suppl. 2011;5:335–43.
Llau Pitarch JV, De Andrés Ibáñez J, Gomar Sancho C, et al. Hemostasis-altering drugs and techniques for regional anesthesia and analgesia: safety recommendations. Rev Esp Anestesiol Reanim. 2005;52:248–50.
Kozek-Langenecker SA, Fries D, Gütl M, et al; Task force on Perioperative Coagulation of the Austrian Society for Anesthesiology and Intensive Care Medicine. Locoregional anesthesia and coagulation inhibitors. Recommendations of the task force on perioperative coagulation of the Austrian Society for anesthesiology and intensive care medicine. Anaesthesist. 2005;54:476–84.
Vandermeulen E, Singelyn F, Vercauteren M, et al; Belgian Association for Regional Anesthesia Working Party on Anticoagulants and Central Nerve Blocks. Belgian guidelines concerning central neural blockade in patients with drug-induced alteration of coagulation: an update. Acta Anaesthesiol Belg. 2005;56:139–46.
Horlocker TT, Bajwa ZH, Ashraf Z, et al. Risk assessment of hemorrhagic complications associated with nonsteroidal antiinflammatory medications in ambulatory pain clinic patients undergoing epidural steroid injection. Anesth Analg. 2002;95:1691–7.
Horlocker TT, Wedel DJ. Anticoagulation and neuraxial block: historical perspective, anesthetic implications, and risk management. Reg Anesth Pain Med. 1998;23:129–34.
Cameron CM, Scott DA, McDonald WM, et al. A review of neuraxial epidural morbidity: experience of more than 8,000 cases at a single teaching hospital. Anesthesiology. 2007;106:997–1002.
Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth. 2007;99:316–28.
Giroud D, Li JM, Urban P, et al. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol. 1992;69:729–32.
Yusuf S, Zhao F, Mehta SR, et al; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators, CURE Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502.
Dawood MM, Gutpa DK, Southern J, et al. Pathology of fatal perioperative myocardial infarction: implications regarding physiopathology and prevention. Int J Cardiol. 1996;57:37–44.
Landesberg G. The pathophysiology of perioperative myocardial infarction: facts and perspectives. J Cardiothorac Vasc Anesth. 2003;17:90–100.
Priebe HJ. Perioperative myocardial infarction—aetiology and prevention. Br J Anaesth. 2005;95:3–19.
Hoffmeister HM, Heller W, Seipel L. Activation markers of coagulation and fibrinolysis: alterations and predictive value in acute coronary syndrome. Thromb Haemost. 1999;82:76–9.
Blake GJ, Ridker PM. Inflammatory biomarkers and cardiovascular risk prediction. J Intern Med. 2002;252:283–94.
Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery. Anesthesiology. 2002;97:215–52.
Savonitto S, D’Urbano M, Caracciolo M, et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of “bridging” antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth. 2010;104:285–91.
Mariscalco G, Bruno VD, Cottini M, et al. Optimal timing of discontinuation of clopidogrel and risk of blood transfusion after coronary surgery. Propensity score analysis. Circ J. 2011;75:2805–12.
Di Minno MN, Prisco D, Ruocco AL, et al. Perioperative handling of patients on antiplatelet therapy with need for surgery. Intern Emerg Med. 2009;4:279–88.
Chassot PG, Marcucci C, Delabays A, et al. Perioperative antiplatelet therapy. Am Fam Physician. 2010;82:1484–9.
Chou S, Eshaghian S, Lamer A, et al. Bridging therapy in the perioperative management of patients with drug-eluting stents. Rev Cardiovasc Med. 2009;10:209–18.
Korte W, Cattaneo M, Chassot PG, et al. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on perioperative Haemostasis of the Society on thrombosis and Haemostasis research (GTH), the working group on perioperative coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost. 2011;105:743–9.
Savonitto S, Caracciolo M, Cattaneo M, et al. Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. J Thromb Haemost. 2011;9:2133–42.
Bell B, Layland J, Poon K, et al. Focused clinical review: periprocedural management of antiplatelet therapy in patients with coronary stents. Heart Lung Circ. 2011;20:438–45.
Douketis JD, Spyropoulos AC, Spencer FA, et al; American College of Chest Physicians. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e326S–50S. Erratum in: Chest. 2012;141:1129.
Hall R, Mazer CD. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesth Analg. 2011;112:292–318.
Parodi G, Marcucci R, Valenti R, et al. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. JAMA. 2011;306:1215–23.
Lardizabal JA, Joshi BK, Ambrose JA. The balance between anti-ischemic efficacy and bleeding risk of antithrombotic therapy in percutaneous coronary intervention: a yin-yang paradigm. J Invasive Cardiol. 2010;22:284–92.
Levy JH, Dutton RP, Hemphill JC 3rd, et al; Hemostasis Summit Participants. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg. 2010;110:354–64.
Huczek Z, Filipiak KJ, Kochman J, et al. Baseline platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and predicts future residual platelet reactivity. A case-control study. Thromb Res. 2010;125:406–12.
Ray JG, Deniz S, Olivieri A, et al. Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel. BMC Cardiovasc Disord. 2003;3:3.
Chassot PG, Delabays A, Spahn DR. Perioperative use of anti-platelet drugs. Best Pract Res Clin Anaesthesiol. 2007;21:241–56.
Ko WM, Ferrante FM. New onset lumbar radicular pain after implantation of an intrathecal drug delivery system: imaging catheter migration. Reg Anesth Pain Med. 2006;31:363–7.
Randelli F, Biggi F, Della Rocca G, et al. Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery. J Orthop Traumatol. 2011;12:69–76.
Bell AD, Roussin A, Cartier R, et al; Canadian Cardiovascular Society. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol. 2011;27:S1–59.
Chernoguz A, Telem DA, Chu E, et al. Cessation of clopidogrel before major abdominal procedures. Arch Surg. 2011;146:334–9.
Ono S, Fujishiro M, Kanzaki H, et al. Conflicting clinical environment about the management of antithrombotic agents during the periendoscopic period in Japan. J Gastroenterol Hepatol. 2011;26:1434–40.
Stone DH, Goodney PP, Schanzer A, et al; Vascular Study Group of New England. Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery. J Vasc Surg. 2011;54:779–84.
Abbate R, Cioni G, Marcucci R, et al. Antithrombotic drugs in women: should we worry more about bleeding? G Ital Cardiol (Rome). 2012;13:407–13.
Ono S, Fujishiro M, Kodashima S, et al. Evaluation of safety of endoscopic biopsy without cessation of antithrombotic agents in Japan. J Gastroenterol. 2012;47:770–4.
Lip GY, Durrani OM, Roldan V, et al. Peri-operative management of ophthalmic patients taking antithrombotic therapy. Int J Clin Pract. 2011;65:361–71.
Gerstein NS, Schulman PM, Gerstein WH, et al. Should more patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome. Ann Surg. 2012;255:811–9.
Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med. 2003;163:901–8.
Horlocker TT. Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy. Br J Anaesth. 2011;107:i96–i106.
Breivik H, Bang U, Jalonen J, et al. Nordic guidelines for neuraxial blocks in disturbed haemostasis from the Scandinavian Society of Anaesthesiology and intensive care medicine. Acta Anaesthesiol Scand. 2010;54:16–41.
Gogarten W, Vandermeulen E, Van Aken H, et al; European Society of Anaesthesiology. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol. 2010;27:999–1015.
Vandermeulen E. Regional anaesthesia and anticoagulation. Best Pract Res Clin Anaesthesiol. 2010;24:121–31.
Frishman WH, Nawarskas JJ, Clark SM. Brilinta® (Ticagrelor): chapter 18 antiplatelet and other antithrombotic drugs. Cardiovascular Pharmacotherapeutics. 2011. http://cardiovascularpharmacotherapeutics.com/2011/08/30/brilinta-ticagrelor-chapter-18-antiplatelet-and-other-antithrombotic-drugs/
Fawole A, Daw HA, Crowther MA. Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban. Cleve Clin J Med. 2013;80:443–51.
Rose A. Periprocedural Anticoagulation – Adult – Inpatient and Ambulatory– Clinical Practice Guideline. UW Health, Original October 2011, Revised February 2013. http://www.uwhealth.org/files/uwhealth/docs/anticoagulation/Periprocedural_Anticoagulation_Guideline.pdf